Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Arjona Ferreira Juan Camilo, holds the title of Head of R&D & CMO at Organon & Co..
On 2026-08-11, the insider transacted 15,653 shares.The shares were transacted at a weighted average price of $3.60 per share, resulting in a total market-relevant value of $56K.
Arjona Ferreira Juan Camilo (Head of R&D & CMO) had withheld for taxes $56K of $OGN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.